Speaker

David Howat

Chief Executive Officer, Mariposa Therapeutics

David Howat, Chief Executive Officer at Mariposa Therapeutics, is speaking at 10th Dermatology Drug Development Summit (Boston, United States of America, 3–5 Nov 2026) in the session “Advancing Disease-Modifying Therapies in Epidermolysis Bullosa Simplex to Move Beyond Wound Management & Restore Structural Integrity”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

10th Dermatology Drug Development Summit
3–5 Nov 2026Boston, United States of America
- SpeakerAdvancing Disease-Modifying Therapies in Epidermolysis Bullosa Simplex to Move Beyond Wound Management & Restore Structural Integrity

More speakers at 10th Dermatology Drug Development Summit

Mudgal Kothekar
Vice President Clinical Development, Sun Pharma Advanced Research Company Ltd.
Maria Akerman
Director, Global Programs, Affibody AB
John Armstrong
Head of Healthcare Banking, Westpark Capital
Frederick Beddingfield
Chief Executive Officer & Director, Rubedo Life Sciences
Dan Brownell
Senior Director, AOBiome
Kenneth Crook
Head of Translational Medicine, Engimmune Therapeutics

See all 32 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by David Howat, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].